Abstract:Background: Lung cancer remains one of the most prevalent cancer types worldwide, with a high mortality rate. Upregulation of programmed cell death protein 1 (PD-1) and its ligand (PD-L1) may represent a key mechanism for evading immune surveillance. Immune checkpoint blockade (ICB) antibodies against PD-1 or PD-L1 are therefore widely used to treat patients with lung cancer. However, the mechanisms by which lung cancer and neutrophils in the microenvironment sustain PD-L1 expression and impart stronger inhibition of CD8+ T cell function remain unclear. Methods: We investigated the role and underlying mechanism by which PD-L1+ lung cancer and PD-L1+ neutrophils impede the function of CD8+ T cells through magnetic bead cell sorting, quantitative real-time polymerase chain reaction (RT-PCR), western blotting, enzyme-linked immunosorbent assays, confocal immunofluorescence, gene silencing, flow cytometry, etc. In vivo efficacy and safety studies were conducted using (Non-obeseDiabetes/severe combined immune deficiency) SCID/NOD mice. Additionally, we collected clinical and prognostic data from 208 patients who underwent curative lung cancer resection between 2017 and 2018. Results: We demonstrated that C-X-C motif chemokine ligand 5 (CXCL5) is markedly overexpressed in lung cancer cells and is positively correlated with a poor prognosis in patients with lung cancer. Mechanistically, CXCL5 activates the phosphorylation of the Paxillin/AKT signaling cascade, leading to upregulation of PD-L1 expression and the formation of a positive feedback loop. Moreover, CXCL5 attracts neutrophils, compromising CD8+ T cell-dependent antitumor immunity. These PD-L1+ neutrophils aggravate CD8+ T cell exhaustion following lung cancer domestication. Combined treatment with anti-CXCL5 and anti-PD-L1 antibodies significantly inhibits tumor growth in vivo. Conclusions: Our findings collectively demonstrate that CXCL5 promotes immune escape through PD-L1 upregulation in lung cancer and neutrophils chemotaxis through autocrine and paracrine mechanisms. CXCL5 may serve as a potential therapeutic target in synergy with ICBs in lung cancer immunotherapy.

CXCL5 Regulation of Proliferation and Migration in Human Non-Small Cell Lung Cancer Cells

CX3CL1 Promotes Lung Cancer Cell Migration and Invasion Via the Src/focal Adhesion Kinase Signaling Pathway.

CCL25 Promotes the Migration and Invasion of Non-Small Cell Lung Cancer Cells by Regulating VEGF and MMPs in a CCR9-dependent Manner.

Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma.

[Expression and Role of CXC Chemokine 5 in Liver Cancer Cells].

High Expression of WNT5A in Small Cell Lung Cancer and Promotion of Cell Migration by Phosphorylation of JNK

Production of CCL20 from Lung Cancer Cells Induces the Cell Migration and Proliferation Through PI3K Pathway.

Cc Chemokine Ligand 18(ccl18) Promotes Migration and Invasion of Lung Cancer Cells by Binding to Nir1 Through Nir1-Elmo1/Doc180 Signaling Pathway

Overexpression of CXCR7 Enhances Metastasis on Lung Cancer Cell

CXCL5 impedes CD8+ T cell immunity by upregulating PD-L1 expression in lung cancer via PXN/AKT signaling phosphorylation and neutrophil chemotaxis

Tumor-derived CXCL5 Promotes Human Colorectal Cancer Metastasis Through Activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin Pathways

Overexpression of CXCR7 accelerates tumor growth and metastasis of lung cancer cells

Neutrophil Infiltration Mediated by CXCL5 Accumulation in the Laryngeal Squamous Cell Carcinoma Microenvironment: A Mechanism by Which Tumour Cells Escape Immune Surveillance.

Roles of CXCL5 on Migration and Invasion of Liver Cancer Cells

CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.

Long Non-Coding RNA Linc00460 Promotes Epithelial-Mesenchymal Transition and Cell Migration in Lung Cancer Cells.

CXCL6 Promotes Non-Small Cell Lung Cancer Cell Survival and Metastasis Via Down-Regulation of Mir-515-5p

Chemokine C-C Motif Receptor 5 and C-C Motif Ligand 5 Promote Cancer Cell Migration under Hypoxia

Comprehensive analysis of the potential biological significance of CCL5 in pan-cancer prognosis and immunotherapy

High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer Via Regulating the NF-κB Pathway

XCR1 Promotes Cell Growth and Migration and is Correlated with Bone Metastasis in Non-Small Cell Lung Cancer.